Cargando…
Clinical Behavior in Metastatic Brain Disease Is Not Influenced by the Immunological Defense Mediated by CD57(+) NK-Cells
Objectives. The purpose of the present study is to verify if the degree of immunological response against metastatic tumors, measured by the number of CD57(+) NK-cells in the tissue of a brain metastasis, influences the later development of new brain metastases or tumor recurrence. Patients and Meth...
Autores principales: | Vaquero, J., Zurita, M., Coca, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265272/ https://www.ncbi.nlm.nih.gov/pubmed/22312544 http://dx.doi.org/10.1155/2012/834852 |
Ejemplares similares
-
Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
por: Tas, Faruk
Publicado: (2012) -
Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells
por: Zhao, Jing-Jing, et al.
Publicado: (2014) -
Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease
por: Nielsen, Carolyn M., et al.
Publicado: (2013) -
Increased Numbers of NK Cells, NKT-Like Cells, and NK Inhibitory Receptors in Peripheral Blood of Patients with Chronic Obstructive Pulmonary Disease
por: Tang, Ying, et al.
Publicado: (2013) -
Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)